Cilengitide: An RGD Pentapeptide ανβ3 and ανβ5 Integrin Inhibitor in Development for Glioblastoma and Other Malignancies

David A Reardon

Neuro-Oncology Program & Department of Surgery, Division of Neurosurgery, 047 Baker House, Duke University Medical Center, Box 3624, Durham, NC27710, USA.
Bart Neyns

Kliniekhoofd Medische Oncologie, Universitair Ziekenhuis Brussel, Oncologisch Centrum, Laarbeeklaan 101-1090 Brussels, Belgium
Michael Weller

Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, CH-8091Zurich, Switzerland
Joerg Christian Tonn

Klinik der LMU, Campus Grosshadern, Marchioninistr. 15, D-81377München, Germany
Louis Burt Nabors

University of Alabama at Birmingham, Department of Neurology, 510 20th Street South FDT 1020, Birmingham, AL35294, USA
Roger Stupp

Centre Hospitalier Universitaire Vaudois, Department of Neurosurgery, Rue du Bugnon 46, CH-1011Lausanne, Switzerland